Edward C. Franklin

immunologist and physician. He made major gains in the study of the aging process with contributions that led to the discovery of a group of abnormal protein aggregates known as amyloids, and played a key role in the fight against Arthritis, Alzheimer's disease, Parkinson's disease, Huntington's disease, Diabetes, and Cardiac arrhythmia.^[1] Franklin was a professor of medicine at the New York University School of Medicine,^[2] a member of the National Academy of Sciences,^[3] president of the American Society for Clinical Investigation,^[2] and director of Irvington House Institute.^[3] The New York Times called Franklin "an international authority on the human immune system".^[2]

Franklin's disease).^[2][3] The Edward C. Franklin Award, which is given for achievements in immunology, has been established in his name.^[4][5]

Philadelphia, Pennsylvania, .^[6][7] In 1955, Franklin started as research associate at the Rockefeller Institute and from 1958 to 1974 served as an assistant and full-time professor of medicine at N.Y.U.^[2] In 1974, He was elected president of the American Society for Clinical Investigation and was elected to the National Academy of Sciences in 1979.^[2] On February 20, 1982, Franklin died of a brain tumor at the age of 54.^[2] Franklin was said to enjoy activities such as skiing, chamber music, literature, art and even owned a farm in the Berkshires that he routinely visited with his family.^[3][6] Franklin was described by a colleague as "a quiet and private man lacking the more overt exuberance of his wife."^[3]

cryoglobulins.^[3]